Digox
NDC Package 76237-294-30
Package Information
Digox is in is used to treat heart failure, usually along with other medications. Marketed by Mckesson Contract Packaging, this product is identified by NDC 76237-294 and is authorized under FDA application ANDA076268.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76237 - Mckesson Contract Packaging
- 76237-294 - Digox
- 76237-294-30 - 6 BLISTER PACK in 1 BOX, UNIT-DOSE / 5 TABLET in 1 BLISTER PACK
- 76237-294 - Digox
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76237-294-30 identifies a specific commercial package of 6 blister pack in 1 box, unit-dose / 5 tablet in 1 blister pack of Digox, labeled by Mckesson Contract Packaging. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Contract Packaging on July 26, 2002. The current certification is valid through September 30, 2017.
What are the primary indications for this medication?
Digoxin is used to treat heart failure, usually along with other medications. It is also used to treat certain types of irregular heartbeat (such as chronic atrial fibrillation). Treating heart failure may help maintain your ability to walk and exercise and may improve the strength of your heart. Treating an irregular heartbeat can also improve your ability to exercise. Digoxin belongs to a class of medications called cardiac glycosides. It works by affecting certain minerals (sodium and potassium) inside heart cells. This reduces strain on the heart and helps it maintain a normal, steady, and strong heartbeat.
How is this Mckesson Contract Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76237029430. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.